@article{100377,
  keywords = {Mycobacterium leprae, Listeria monocytogenes, Leprosy,  Metagenomic next-generation sequencing, Systemic lupus erythematosus,  Case report},
  author = {Zhao C and Liu Z},
  title = {A case report and literature review: Mycobacterium leprae infection diagnosed by metagenomic next-generation sequencing of cerebrospinal fluid},
  abstract = {<p><strong>Background:</strong> Leprosy is a chronic infectious disease caused by Mycobacterium leprae (M. leprae) that is responsible for deformities and irreversible peripheral nerve damage and has a broad spectrum of clinical and serological manifestations. Leprosy primarily affects the peripheral nerves and rarely presents with central nervous system involvement. Diagnosing leprosy can still be difficult in some cases, especially when the infection involves uncommon clinical manifestations and extracutaneous sites. Delayed diagnosis and treatment of leprosy may lead to irreversible damage and death.</p>

<p><strong>Case Presentation:</strong> We report a case of a 30-year-old female presenting with “repeated high fever with symptoms of headache for 14 days”. On the day of admission, physical signs of lost eyebrows and scattered red induration patches all over her body were observed. The patient’s diagnosis was based on the clinical characteristics using a combination of metagenomic next-generation sequencing (mNGS) of cerebrospinal fluid (CSF) and slit-skin smear. After confirming Listeria meningitis and multibacillary leprosy with erythema nodosum leprosum (ENL), a type 2 reaction, she was treated with ampicillin sodium, dapsone, rifampicin, clofazimine, methylprednisolone, and thalidomide. At the 1-year follow-up, the frequency and severity of headaches have significantly decreased and a good clinical response with improved skin lesions was found.</p>

<p><strong>Conclusion: </strong>This case highlights the importance of considering leprosy, which is a rare and underrecognized disease, in the differential diagnosis of skin rashes with rheumatic manifestations, even in areas where the disease is not endemic, and physicians should be alerted about the possibility of central nervous system infections. In addition, mNGS can be used as a complementary diagnostic tool to traditional diagnostic methods to enhance the diagnostic accuracy of leprosy.</p>
},
  year = {2024},
  journal = {BMC Infectious Diseases},
  volume = {24},
  pages = {1-7},
  publisher = {Springer Science and Business Media LLC},
  issn = {1471-2334},
  url = {https://bmcinfectdis.biomedcentral.com/counter/pdf/10.1186/s12879-024-09473-z.pdf},
  doi = {10.1186/s12879-024-09473-z},
  language = {ENG},
}